山東新華製藥股份：2022年年報.pdf

1、目錄 CONTENTS1二零二二年年報山東新華製藥股份有限公司2公司基本情況簡介Company Information5會計數據和業務數據摘要Summary of Financial and Operating Results9股本變動及股東情況Changes in Share Capital Structure and Information on Shareholders18董事、監事、高級管理人員和員工情況Directors,Supervisors,Senior Officers and Staff 34公司管治及內控報告Corporate Governance and Internal

2、 Control Report 63股東大會簡介Summarised Report of the General Meetings65董事長報告Chairmans Statement73經營管理研討與分析Management Discussion and Analysis95董事會報告Report of the Board of Directors138環境與社會責任Environmental and social responsibility151監事會報告Report of the Supervisory Committee154重要事項Important Issues168財務報告Fin

3、ancial Report408備查文件Documents Available for Inspection重要提示本公司董事會、監事會及董事、監事、高級管理人員保證本報告所載資料不存在任何虛假記載、誤導性陳述或者重大遺漏，並對其內容的真實性、準確性和完整性承擔個別及連帶責任。董事長賀同慶先生、財務負責人侯寧先生、財務資產部經理何曉洪先生聲明：保證本年度報告中財務報告真實、完整。本報告分別以中文及英文刊載。如中英文有任何差異，概以中文為準。Important:The board of directors(“Board of Directors”)and the supervisory comm

4、ittee(“Supervisory Committee”)and each of the directors(“Directors”),the supervisors(“Supervisors”)and the senior management(collectively,the“Senior Officers”)of Shandong Xinhua Pharmaceutical Company Limited(the“Company”)hereby confirm that there are no false representations,material omissions or m

5、isleading statements contained in this report,and they,severally and jointly,accept full responsibility for the truthfulness,accuracy and completeness of the contents of this report.The chairman(Mr.He Tongqing),financial controller(Mr.Hou Ning)and the chief of the finance department(Mr.He Xiaohong)o

6、f the Company hereby declare that the financial report of the Company for 2022 is true and complete.This report has been prepared in both Chinese and English.In the event of any discrepancy between the two versions,the Chinese version shall prevail.公司基本情況簡介COMPANY INFORMATION2022 ANNUAL REPORTSHANDO